Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion type Assertion NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_head.
- NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion description "[We investigated the tolerance and possible antiviral effect of the administration of daily doses of recombinant human granulocyte-macrophage colony-stimulating factor (3, 1 or 0.5 micrograms/kg body wt) to nine patients with chronic hepatitis B, alone or in combination with 5 MU interferon-alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_provenance.
- NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion evidence source_evidence_literature NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_provenance.
- NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion SIO_000772 8406350 NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_provenance.
- NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion wasDerivedFrom befree-20140225 NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_provenance.
- NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_assertion wasGeneratedBy ECO_0000203 NP239633.RAT5Y2qRkAbrLF7BKRfYCd6IO6fozZz2XfvKQoSoGtssM130_provenance.